Good News For Originators Of Antibody Products

Law360, New York (September 29, 2014, 1:55 PM EDT) -- In Eli Lilly and Company v. Human Genome Sciences Inc., the English Patents Court (Justice Nicholas Roger Warren) recently gave its interpretation of the EU Court of Justice's most recent decision in relation to supplementary protection certificates ("SPCs"). In doing so, the court confirmed that SPCs are available based on patents with claims that define the product in functional terms only; this is particularly important for patents relating to antibodies....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!